Female Urogenital Diseases and Pregnancy Complications

217 trials 111 recruiting

Filter these 217 trials by phase, country and sponsor.

Open in Search →

Hydroxychloroquine treatment for Recurrent Pregnancy Loss: a randomized double-blind placebo-controlled trial Recruiting

2024-515579-36-00 Recurrent Pregnancy Loss 4 2017-04-12
Modified autologous leukocyte cells for the treatment of acute kidney injury after cardiac surgery Ended

2023-504610-30-01 Acute kidney injury after cardiac surgery 4 2026-04-29
A clinical study to investigate the antibacterial efficacy of arbutin metabolites in urine. Ended

2024-519011-34-00 Urinary Tract Infection 3 2025-08-04
An open label, single-arm, phase 2 study of perioperative sacituzumab govitecan in combination with zimberelimab and domvanalimab for patien… Ended

2023-504420-26-00 Bladder Cancer 4 2025-01-13
Tuvusertib Combined with Niraparib or Lartesertib in Participants with Epithelial Ovarian Cancer (DDRiver EOC 302) Ended

2024-511202-23-00 Epithelial ovarian cancer that progressed on prior PARP 4 2024-10-31
A study to evaluate the efficacy and safety of AMY109 in women with endometriosis Ended

2023-507289-14-00 Endometriosis 4 2024-10-21
StayDry Ended

2023-510280-35-00 Daytime urinary incontinence 6 2024-05-27
A Study to Evaluate the Efficacy and Safety of Sefaxersen, an Antisense Inhibitor of Complement Factor B, in Patients with Primary IgA Nephr… Ended

2022-502102-32-00 Primary Immunoglobulin A (IgA) Nephropathy 5 2023-11-16
Sentinel node detection with 99Tc albumin nanocolloid and indocianine green (ICG) in patients with epithelial ovarian cancer in early stages… Ended

2023-505667-37-00 Epithelial ovarian cancer in early stages. 4 2023-10-06
A PILOT PROOF-OF–CONCEPT STUDY TO ASSESS THE EFFICACY AND SAFETY OF A 6 MONTHS RAVULIZUMAB TREATMENT IN PATIENTS WITH FLARES OF CORTICOSTERO… Ended

2024-512154-24-00 IgA nephropathy 11 2023-05-26
Does progesterone luteal phase support increase live birth rates in couples undergoing intra-uterine insemination with Mild Ovarian HyperSti… Ended

2022-501534-33-00 Unexplained Subfertility, infertility 6 2023-03-06
A double-blind randomized placebo-controlled four-arm trial to assess the efficacy of oral bicarbonate and intravenous butylscopolamine brom… Ended

2024-511848-55-00 childbirth 5 2023-01-03
A study to learn more about how well elinzanetant works and how safe it is compared to placebo for the treatment of hot flashes caused by an… Ended

2023-508265-33-00 Vasomotor symptoms caused by adjuvant endocrine therapy 5 2022-10-13
A phase 2 study to investigate the effectiveness of combination immunotherapy followed by chemoradiation of the tumor in patients with bladd… Ended

2024-512211-41-00 Urothelial carcinoma of the bladder and bladder cancer 9 2022-01-26
Prospective, randomized, neoadjuvant phase II study with combination immuno-oncology in primary clear cell renal cell cancer at risk for rec… Ended

2024-515514-40-00 Resectable intermediate to high-risk clear cell RCC (ac 4 2022-01-05
Improvement of Live Babies Rates After ICSI, Using cpFT Ended

2024-514350-78-00 Infertility 5 2021-07-29
Vaginal progesterone as luteal support for improvement of live birth in frozen/thawed in-vitro fertilization natural cycles; a multicenter, … Ended

2024-512844-40-00 Infertility 6 2021-04-20
NORTH-REG Dwell-Time Study Ended

2023-505936-37-00 Urothelial cancer 6 2021-02-03
TROPHAMET, a phase I/II trial of Avelumab and METhotrexate in low-risk gestational TROPHoblastic neoplasias as first line treatment Ended

2024-515434-32-00 Low-risk gestational trophoblastic neoplasia 9 2020-02-12
A study to determine whether the addition of Dostarlimab (TSR-042) delays recurrence of advanced endometrial cancer Ended

2023-506551-23-00 Recurrent or primary advanced (Stage III or IV) endomet 5 2019-11-21
Treatment Of Metastatic Bladder cancer at the time Of biochemical reLApse following radical cystectomy - TOMBOLA Ended

2024-510865-41-00 Urothelial cancer 6 2019-09-26
Finding the optimal dosing of recombinant FSH Ended

2024-517312-30-00 Subfertility in need of ICSI treatment 6 2019-06-19
The FIRST (First-line ovarian cancer treatment with Niraparib plus TSR-042) Study Ended

2024-510605-28-00 Stage 3 or 4 Non-mucinous Epithelial Ovarian Cancer 5 2018-11-27
Frozen-thawed embryo transfer in a natural versus artificial cycle: a randomized clinical trial. Ended

2024-511890-30-03 Subfertility 6 2018-06-26